Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 49 min ago
PreprintAll rights reservedmedRxiv

Effectiveness of nirsevimab against hospitalization for RSV bronchiolitis according to RSV lineages

  • M. Barbier1
  • C. Levy
  • R. Cohen
  • Z. Valtuille
  • Z. Assad
  • J.-s. Yang
  • I. Fafi
  • L. Lenglart
  • S. Bechet
  • L. Osei
  • E. Launay
  • C. Gras Le Guen
8 more authors
  • V. Gajdos
  • E. Jeziorski
  • L. De Pontual
  • R. Basmaci
  • M.-A. Rameix-Welti
  • N. Ouldali
  • S. Fourati
  • French RSV Surveillance Network
  1. 1Universite Paris Cite and Universite Sorbonne Paris Nord, Inserm, IAME, F-75018 Paris, France
Read full textPDFDOICite

Related

  1. Assessing the Effects of Nirsevimab on Respiratory Syncytial Virus Bronchiolitis Outcomes: Insights From A Two‐Season Analysis
    Marta Agüera, Aleix Soler‐Garcia, Sara Castellà +10
    Pediatric pulmonologyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis
    Léa Lenglart, Luigi Titomanlio, Ilaria Alberti +40
    PLoS MedicinePeer-reviewedCC BY 4.0Full textGeneral biologyStatisticsHALPLOS
  3. Effectiveness of nirsevimab against RSV hospitalisation in infants, Basque Country 2024-2025
    C Cabrera Bufau, P Latasa Zamalloa, JA Gonzalez Martin +2
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMCEurope PMC
  4. Pediatric Influenza Vaccine Effectiveness Against Emergency Visits and Hospitalization in Canada: 2024-2025 and 2025-2026 seasons
    J. C. Kwong, D. M. Goldfarb, M. Bhatt +21
    medRxivPreprintCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsmedRxiv
  5. Clinical Profile of RSV Breakthrough Infections After Nirsevimab Introduction.
    Anna Chiara Vittucci, Livia Antilici, Alessandra Salvatori +9
    VirusesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{barbier2026effectiveness,
  title = {{Effectiveness of nirsevimab against hospitalization for RSV bronchiolitis according to RSV lineages}},
  author = {M. Barbier and C. Levy and R. Cohen and Z. Valtuille and Z. Assad and J.-s. Yang and I. Fafi and L. Lenglart and S. Bechet and L. Osei and E. Launay and C. Gras Le Guen and V. Gajdos and E. Jeziorski and L. De Pontual and R. Basmaci and M.-A. Rameix-Welti and N. Ouldali and S. Fourati and French RSV Surveillance Network},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.28.26364231},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.28.26364231v1},
}
RIS
TY  - UNPB
TI  - Effectiveness of nirsevimab against hospitalization for RSV bronchiolitis according to RSV lineages
AU  - M. Barbier
AU  - C. Levy
AU  - R. Cohen
AU  - Z. Valtuille
AU  - Z. Assad
AU  - J.-s. Yang
AU  - I. Fafi
AU  - L. Lenglart
AU  - S. Bechet
AU  - L. Osei
AU  - E. Launay
AU  - C. Gras Le Guen
AU  - V. Gajdos
AU  - E. Jeziorski
AU  - L. De Pontual
AU  - R. Basmaci
AU  - M.-A. Rameix-Welti
AU  - N. Ouldali
AU  - S. Fourati
AU  - French RSV Surveillance Network
PY  - 2026
DA  - 2026/09/28
PB  - medRxiv
DO  - 10.64898/2026.09.28.26364231
UR  - https://www.medrxiv.org/content/10.64898/2026.09.28.26364231v1
ER  -